Dr. Reddy s Laboratories share price: Jefferies Maintains Buy rating on the stock © Provided by Zee Business
Jefferies channel checks indicate API supply constraints for generic manufacturers of Vascepa. Amarin has added EU and China as new markets, thereby committing more volumes to its regular API vendor base. CCSB Taiwan has been the sole/key API supplier for both Hikma and Dr. Reddy s and is currently facing scale-up challenges. Both generics should gradually ramp-up through 2022 as API supplies scale-up. Jefferies cuts Dr. Reddy s Laboratories FY22E EPS by 1%. Maintain Buy rating on Dr. Reddy s Laboratories. Dr. Reddy s Laboratories share price today is Rs 4347, down Rs 80 or 1.8%.
Buy IndusInd Bank; Target Of Rs 1200: Motilal Oswal
moneycontrol.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from moneycontrol.com Daily Mail and Mail on Sunday newspapers.
Buy JSW Energy; Target Of Rs 84: Motilal Oswal
moneycontrol.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from moneycontrol.com Daily Mail and Mail on Sunday newspapers.